Cost-effectiveness of preventing weight gain and obesity: What we know and what we need to know

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 12, Issue 3, 2012, Pages 297-305

  Gandjour, Afschin ^a,b,c  

^a FRANKFURT SCHOOL OF FINANCE AND MANAGEMENT   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

cost effectiveness; obesity; physical activity; prevention

Indexed keywords

ALGORITHM; BODY MASS; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ENERGY EXPENDITURE; HEALTH CARE COST; HEALTH PROMOTION; HUMAN; INCIDENCE; INSULIN RESISTANCE; LIFE EXPECTANCY; OBESITY; PHYSICAL ACTIVITY; QUALITATIVE ANALYSIS; QUALITY OF LIFE; REVIEW; WEIGHT GAIN; WEIGHT REDUCTION;

COMPUTER SIMULATION; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; MOTOR ACTIVITY; OBESITY; RESEARCH DESIGN; TIME FACTORS; WEIGHT GAIN;

EID: 84864256788     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.12.13     Document Type: Review

References (71)

1. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. WHO, Geneva, Switzerland (2009
2. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: Payer-and service-specific estimates. Health Aff. 28(5), w822-w831 (2009
3. Müller-Riemenschneider F, Reinhold T, Willich SN. Cost-effectiveness of interventions promoting physical activity. Br. J. Sports Med. 43(1), 70-76 (2009)
4. John J, Wenig CM, Wolfenstetter SB. Recent economic findings on childhood obesity: Cost-of-illness and costeffectiveness of interventions. Curr. Opin. Clin. Nutr. Metab. Care 13(3), 305-313 (2010
5. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood d its consequences for life expectancy: A life-table analysis. Ann. Intern. Med. 138(1), 24-32 (2003
6. Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J. Health Econ. 16(1), 33-64 (1997
7. Nyman JA. Should the consumption of survivors be included as a cost in costutility analysis? Health Econ. 13(5), 417-427 (2004
8. Gandjour A. Consumption costs and earnings during added years of life - a reply to Nyman. Health Econ. 15(3), 315-317; discussion 319 (2006
9. Lee RH. Future costs in cost effectiveness analysis. J. Health Econ. 27(4), 809-818 (2008
10. Feenstra TL, Van Baal PH, Gandjour A, Brouwer WB. Future costs in economic evaluation. A comment on Lee. J. Health Econ. 27(6), 1645-1649; discussion 1650 (2008
11. Liljas B, Karlsson GS, Stålhammar NO On future non-medical costs in economic evaluations. Health Econ. 17(5), 579-591 (2008
12. Kruse M, Sørensen J, Gyrd-Hansen D. Future costs in cost-effectiveness analysis: An empirical assessment. Eur. J. Health Econ. 13(1), 63-70 (2012
13. Van Baal PH, Feenstra TL, Polder JJ, Hoogenveen RT, Brouwer WB. Economic evaluation and the postponement of health care costs. Health Econ. 20(4), 432-445 (2011
14. Allison DB, Zannolli R, Narayan KM. The direct health care costs of obesity in the United States. Am. J. Public Health 89(8), 1194-1199 (1999
15. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G. Lifetime health and economic consequences of obesity. Arch. Intern. Med. 159(18), 2177-2183 (1999
16. Daviglus ML, Liu K, Yan LL et al. Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age. JAMA 292(22), 2743-2749 (2004)
17. Lakdawalla DN, Goldman DP, Shang B. The health and cost consequences of obesity among the future elderly. Health Aff. 24(Suppl. 2), W5R30-W5R41 (2005
18. Tucker DM, Palmer AJ, Valentine WJ, Roze S, Ray JA. Counting the costs of overweight and obesity: modeling clinical and cost outcomes. Curr. Med. Res. Opin 22(3), 575-586 (2006
19. Finkelstein EA, Trogdon JG, Brown DS, Allaire BT, Dellea PS, Kamal-Bahl SJ. The lifetime medical cost burden of overweight and obesity: Implications for obesity prevention. Obesity 16(8), 1843-1848 (2008
20. Yang Z, Hall AG. The financial burden of overweight and obesity among elderly Americans: The dynamics of weight, longevity, and health care cost. Health Serv Res. 43(3), 849-868 (2008
21. Cai L, Lubitz J, Flegal KM, Pamuk ER. The predicted effects of chronic obesity in middle age on medicare costs and mortality. Med. Care 48(6), 510-517 (2010
22. Van Baal PH, Polder JJ, de Wit GA et al. Lifetime medical costs of obesity: Prevention no cure for increasing health expenditure. PLoS Med. 5(2), e29 (2008
23. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 293(15), 1861-1867 (2005
24. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes. Res. 6(2), 97-106 (1998
25. Gandjour A, Lauterbach KW. Does prevention save costs? Considering deferral of the expensive last year of life. J. Health Econ. 24(4), 715-724 (2005
26. Sabia JJ, Rees DI. Body weight and wages: Evidence from Add Health. Econ. Hum. Biol. 10(1), 14-19 (2012
27. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N. Engl. J. Med. 357(4), 370-379 (2007
28. Sassi F. Obesity and the Economics of Prevention: Fit Not Fat. OECD Publishing, Paris, France (2010
29. Jakicic JM. The role of physical activity in prevention and treatment of body weight gain in adults. J. Nutr. 132(12), 3826S-3829S (2002
30. Lee IM, Djoussé L, Sesso HD, Wang L, Buring JE. Physical activity and weight gain prevention. JAMA 303(12), 1173-1179 (2010
31. Wang LY, Yang Q, Lowry R, Wechsler H Economic analysis of a school-based obesity prevention program. Obes. Res. 11(11), 1313-1324 (2003
32. Galani C, Schneider H, Rutten FF. Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland. Int. J. Public Health 52(6), 372-382 (2007
33. Moodie M, Haby MM, Swinburn B, Carter R. Assessing cost-effectiveness in obesity: Active transport program for primary school children-TravelSMART Schools Curriculum program. J. Phys. Act. Health 8(4), 503-515 (2011
34. Magnus A, Haby MM, Carter R, Swinburn B. The cost-effectiveness of removing television advertising of high-fat and/or high-sugar food and beverages to Australian children. Int. J. Obes. 33(10), 1094-1102 (2009
35. Moodie M, Haby M, Galvin L, Swinburn B, Carter R. Cost-effectiveness of active transport for primary school children - Walking School Bus program. Int. J. Behav. Nutr. Phys. Act. 6, 63 (2009
36. Moodie ML, Carter RC, Swinburn BA, Haby MM. The cost-effectiveness of Australia's Active After-School Communities program. Obesity 18(8), 1585-1592 (2010
37. Sacks G, Veerman JL, Moodie M, Swinburn B. 'Traffic-light' nutrition labelling and 'junk-food' tax: A modelled comparison of cost-effectiveness for obesity prevention. Int. J. Obes. 35(7), 1001-1009 (2011)
38. Brown HS 3rd, Pérez A, Li YP, Hoelscher DM, Kelder SH, Rivera R. The cost- effectiveness of a school-based overweight program. Int. J. Behav. Nutr. Phys. Act. 4, 47 (2007
39. James WPT, Jackson-Leach R, Mhurchu CN et al. Overweight and obesity (high body mass index)In: Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Ezzati M, Lopez AD, Rodgers A, Murray CJL (Eds)World Health Organization, Geneva, Switzerland, 497-596 (2004
40. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J. Chronic Dis. 32(8), 563-576 (1979
41. Waaler HT. Height, weight and mortality The Norwegian experience. Acta Med. Scand. Suppl. 679, 1-56 (1984
42. Garrison RJ, Castelli WP. Weight and thirty-year mortality of men in the Framingham Study. Ann. Intern. Med 103(6 Pt 2), 1006-1009 (1985
43. Kivimäki M, Ferrie JE, Batty GD et al. Optimal form of operationalizing BMI in relation to all-cause and cause-specific mortality: The original Whitehall study. Obesity 16(8), 1926-1932 (2008
44. Andreyeva T, Sturm R, Ringel JS. Moderate and severe obesity have large differences in health care costs. Obes. Res. 12(12), 1936-1943 (2004
45. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med. 122(7), 481-486 (1995
46. Tremollieres FA, Pouilles JM, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: A longitudinal study in 155 early postmenopausal women. J. Clin. Endocrinol. Metab. 77(3), 683-686 (1993
47. Gorsky RD, Pamuk E, Williamson DF, Shaffer PA, Koplan JP. The 25-year health care costs of women who remain overweight after 40 years of age. Am. J. Prev. Med. 12(5), 388-394 (1996
48. Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J. Appl. Physiol. 99(3), 1193-1204 (2005
49. Roux L, Pratt M, Tengs TO et al. Cost effectiveness of community-based physical activity interventions. Am. J. Prev. Med. 35(6), 578-588 (2008
50. Cobiac LJ, Vos T, Barendregt JJ. Cost-effectiveness of interventions to promote physical activity: A modelling study. PLoS Med. 6(7), e1000110 (2009
51. Kesaniemi YK, Danforth E Jr, Jensen MD, Kopelman PG, Lefèbvre P, Reeder BA. Dose-response issues concerning physical activity and health: An evidence-based symposium. Med. Sci. Sports Exerc. 33(Suppl. 6), S351-S358 (2001
52. Haskell WL, Lee IM, Pate RR et al.; Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the erican Heart Association Circulation 116(9), 1081-1093 (2007
53. Hootman J. Physical activity, fitness, and joint and bone health. In: Physical Activity and Health. Bouchard C, Blair SN, Haskell WL (Eds)Human Kinetics, IL, USA, 219-230 (2007)
54. Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals? JAMA 286(23), 2988-2992 (2001
55. Gandjour A. A model to predict the cost-effectiveness of disease management programs. Health Econ. 19(6), 697-715 (2010
56. Gandjour A. Investment in quality improvement: How to maximize the return. Health Econ. 19(1), 31-42 (2010
57. Dishman RK, Buckworth J. Increasing physical activity: A quantitative synthesis. Med. Sci. Sports Exerc. 28(6), 706-719 (1996
58. Marcus BH, Dubbert PM, Forsyth LH et al. Physical activity behavior change: Issues in adoption and maintenance. Health Psychol. 19(Suppl. 1), 32-41 (2000
59. King AC, Rejeski WJ, Buchner DM. Physical activity interventions targeting older adults. A critical review and recommendations. Am. J. Prev. Med. 15(4), 316-333 (1998
60. Brouwer WB, Koopmanschap MA. On the economic foundations of CEA. Ladies and gentlemen, take your positions! J. Health Econ. 19(4), 439-459 (2000
61. Hagberg LA, Lindholm L. Measuring the time costs of exercise: A proposed measuring method and a pilot study. Cost Eff. Resour. Alloc. 8, 9 (2010
62. Gustafsson O, Carlsson P, Norming U, Nyman CR, Svensson H. Costeffectiveness analysis in early detection of prostate ancer: An evaluation of six screening strategies in a randomly selected population of 2,400 men. Prostate 26(6), 299-309 (1995
63. Hatziandreu EI, Koplan JP, Weinstein MC, Caspersen CJ, Warner KE. A cost-effectiveness analysis of exercise as a health promotion activity. Am. J. Public Health 78(11), 1417-1421 (1988
64. Weinstein AR, Sesso HD. Joint effects of physical activity and body weight on diabetes and cardiovascular disease. Exerc Sport Sci. Rev. 34(1), 10-15 (2006
65. Fogelholm M. Physical activity, fitness and fatness: Relations to mortality, morbidity and disease risk factors. A systematic review. Obes. Rev. 11(3), 202-221 (2010
66. Lee DC, Sui X, Blair SN. Does physical activity ameliorate the health hazards of obesity? Br. J. Sports Med. 43(1), 49-51 (2009)
67. Wang G, Pratt M, Macera CA, Zheng ZJ, Heath G. Physical activity, cardiovascular disease, and medical expenditures in U.S. adults. Ann. Behav. Med. 28(2), 88-94 (2004
68. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 326(7404), 1419 (2003
69. Franco OH, Bonneux L, De Laet C, Peeters A, Steyerberg EW, Mackenbach JP. The Polymeal: A more natural, safer, and probably tastier (than the Polypill)strategy to reduce cardiovascular disease by more than 75%. BMJ 329(7480), 1447-1450 (2004
70. Schlander M. Reference case. In: Encyclopedia of Medical Decision Making. Kattan M (Ed.)SAGE, CA, USA (2009
71. Gandjour A, Gafni A. The German method for setting ceiling prices for drugs: In some cases less data are required. Expert Rev. Pharmacoecon. Outcomes Res. 11(4), 403-409 (2011)